Gainers: Aphria (APHA) +36%. Natural Grocers by Vitamin Cottage (NGVC) +33%. BlackLine (BL) +29%. Regional Health Properties (RHE) +22%. Griffon Corporatio
Gainers: Aphria (APHA) +31%. Regional Health Properties (RHE) +20%. Coherus BioSciences (CHRS) +16%. Corcept Therapeutics (CORT) +12%. Cassava Sciences (SA
Nano cap Obalon Therapeutics (OBLN) slumps 27% premarket on modest volume. Shares have lost half their value since closing at $9.60 on July 23. This mornin
Tariff tantrums hit the broader stock markets last month, leading to the worst May after 2010. Dow Jones fell 6.7%, the S&P 500 shed 6.6% and the Nasdaq tumbled 7.9%. Rough...
It has been a choppy ride for the stock market so far this year. The U.S.-China trade war, uncertainty over Brexit, tech weakness, declining oil prices, the U.S. Federal...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Buy||Buy||Sell||Strong Sell|
|Technical Indicators||BUY||Sell||Strong Buy||BUY||Strong Sell|
|Summary||Buy||Neutral||Strong Buy||Neutral||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Falling Three Methods||1H||2||Sep 13, 2019 01:00PM|
|Bullish doji Star||1D||6||Sep 05, 2019|
|Stick Sandwich||30||7||Sep 13, 2019 12:00PM|
Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.